| Patent application number | Description | Published |
|---|
| 20080207528 | HCV PROTEASE INHIBITORS - This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat hepatitis C virus infection. | 08-28-2008 |
| 20080292626 | KINESIN INHIBITORS - This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder. | 11-27-2008 |
| 20090042932 | ANTIMICROBIAL PARENTERAL FORMULATION - This invention relates to a parenteral formulation containing an effective amount of the compound of the following formula I: | 02-12-2009 |
| 20090111757 | HCV PROTEASE INHIBITORS - Compounds of formula (I): | 04-30-2009 |
| 20090143302 | PYRIMIDINE COMPOUNDS - This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification. | 06-04-2009 |
| 20090214529 | KINESIN INHIBITORS - This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder. | 08-27-2009 |
| 20090264339 | Heterocyclic Compounds - This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds. | 10-22-2009 |
| 20090286814 | HCV PROTEASE INHIBITORS - This invention relates to macrocyclic compounds of formula (I) or (II) shown in the specification. These compounds can be used to treat hepatitis C virus infection. | 11-19-2009 |
| 20100004282 | TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA INFECTION - This invention relates to a method of treating infection by methicillin-nonsusceptibale bacteria, vancomycin-nonsusceptibale bacteria, penicillin-nonsusceptibale bacteria, clarithromycin-nonsusceptibale bacteria, or metronidazole-nonsusceptibale bacteria by administering to a subject in need thereof an effective amount of a compound of the following formula: | 01-07-2010 |
| 20100041697 | PNEUMONIA TREATMENT - This invention relates to a method of treating pneumonia by orally administering to a subject in need thereof a quinolone compound of formula (I), shown in the disclosure, at a daily dose of 2-30 mg/kg. | 02-18-2010 |
| 20100120719 | LYOPHILIZATION FORMULATION - This invention relates to a pharmaceutical kit containing a lyophilized preparation of a pyrimidine compound described in the specification. Also disclosed is a lyophilization process for making this preparation. | 05-13-2010 |
| 20100152452 | STEREOSELECTIVE SYNTHESIS OF PIPERIDINE DERIVATIVES - This invention relates to dialdehyde or dinitrile compounds, which are useful for stereoselective synthesis of piperidine, pyrrolidine, and azepane derivatives. | 06-17-2010 |
| 20110065737 | HCV PROTEASE INHIBITORS - This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection. | 03-17-2011 |
